All News

In the eighth episode of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, spoke with Mackenzie Perry, PharmD, who is a part of continuing education programming.

Finch was still able to continue dosing patients in its past-ongoing PRISM-EXT phase 2 open-label trial of CP101 in recurrent CDI, because the CP101 lots used for PRISM-EXT were manufactured from material donated prior to December 1, 2019.

In recent years, the auditing process has evolved into a full-blown investigation, often requiring pharmacies to submit hundreds of pages of documentation

Michael Abrams, MPH, PhD, senior health researcher at Public Citizen’s Health Research Group, discusses whether classification of gabapentin as schedule V would end patients’ access to the drug.

In the third part of the series, we further explore the factors that contribute to overall happiness in a position.

Tapping their specific skill sets and training can help serve patients more effectively, although challenges exist.

Kelsey Ramsden, co-founder, president, and CEO at MindCure, discussed the potential links between sexual trauma and hypoactive sexual desire disorder in women.

Exenatide (Bydureon) is a GLP-1 receptor agonist indicated to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings.

Australian Dream is indicated for arthritis pain relief.

Study highlights the impressive efficacy of direct-acting antivirals, which have cure rates in the range of 98% in patients with hepatitis C.

Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, discusses what oncology pharmacists should understand about rucaparib when treating ovarian cancer.

Implement technology solutions, initiate clinical services, and shift to a proactive mindset, Michele Belcher says.

The commission “Time for United Action on Depression,” authored by 25 experts from 11 countries, seeks to unify global efforts among governments, health care providers, researchers, people living with depression, and their families to improve care and prevention, fill knowledge gaps, and increase awareness.

Help patients get regular checkups and show them how to use BP machines and improve adherence.

Insurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.

These individuals, who were also more likely to require treatment in the intensive care unit, should get their vaccines and booster shots, investigators say.

Headache disorders most affect the ability to do physical labor, decision-making skills, and memory, investigators from the University of Copenhagen say.

Last month, the FDA approved empagliflozin (Jardiance) to lower the risk of cardiovascular death and hospitalization for heart failure in adult patients.

Supplemental new drug application submitted to the FDA for the approval of darolutamide (Nubeqa) plus docetaxel in patients with metastatic hormone-sensitive prostate cancer.

Exenatide (Byetta) is a GLP-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

Advil Sinus Congestion & Pain offers temporary relief of the symptoms associated with cold or flu, such as sinus pressure, headache, and fever.

The COVID-19 pandemic highlighted the importance of managing infections properly globally and the need for stewardship networks among partners.

Despite early excitement about the potential for pharmacists to prescribe COVID-19 oral antivirals, the program does not provide that ability.

A patient’s ability to pay for specialty medications will continue to be an issue because drug costs are prohibitive and add barriers to accessibility.

The risk of death from CVD was approximately 15% lower for those with the highest vegetable intake compared to the lowest vegetable intake.

Investigators advise third short for patients with weakened immune system, especially organ transplant recipients.

Although the risks are still, individuals with a history of migraines should be aware of and consult with their physicians, investigators say.

Phase 3 TROPiCS-02 study continues to follow patients for overall survival, a key secondary endpoint.